Skip to main content
. 2015 Apr 28;11(3):e267–e278. doi: 10.1200/JOP.2015.003673

Table 1.

Characteristics of Physicians and Patient-Physician Links

graphic file with name jop00315-3371-t1a.jpg

graphic file with name jop00315-3371-t1b.jpg

graphic file with name jop00315-3371-t1c.jpg

Characteristic Physicians
Patient-Physician Links
No. % No. %
Total 1,601 100.0 4,620 100.0

Physicians
Tumor board participation
    Never 67 4.2 140 3.0
    < Quarterly 132 8.2 407 8.8
    Quarterly 132 8.2 346 7.5
    Monthly 408 25.5 1,301 28.2
    Weekly 862 53.8 2,426 52.5
Tumor board serves pretreatment planning function*
    No 258 17.6 828 19.4
    Yes 1,207 82.4 3,434 80.6
Tumor board includes evaluation of treatment decisions*
    No 113 7.7 315 7.5
    Yes 1,351 92.3 3,898 92.5
Tumor board reviews only challenging patient cases*
    No 602 41.3 1,688 39.7
    Yes 856 58.7 2,563 60.3
Tumor board reviews variety of cancer sites*
    No 189 13.0 399 9.5
    Yes 1,271 87.1 3,820 90.5
Tumor board serves only as teaching session*
    No 1,278 87.9 3,740 89.0
    Yes 176 12.1 461 11.0
Age, years
    < 40 356 22.2 617 13.4
    40 to 49 459 28.7 1,512 32.7
    50 to 54 253 15.8 999 21.6
    55 to 59 250 15.6 788 17.1
    ≥ 60 276 17.2 691 15.0
    Not ascertained 7 0.4 13 0.3
Sex
    Male 1,312 82.0 3,913 84.7
    Female 272 17.0 659 14.3
    Not ascertained 17 1.1 48 1.0
Specialty
    Medical oncologist 529 33.0 1877 40.6
    Radiation oncologist 235 14.7 450 9.7
    Thoracic surgeon 130 8.1 491 10.6
    Colorectal surgeon or surgical oncologist 111 6.9 433 9.4
    General surgeon 596 37.2 1369 29.6
Practice structure
    HMO 272 17.0 1,223 26.5
    VA or government 241 15.1 88 1.9
    Office
        Solo practice 179 11.2 427 9.2
        One-specialty group 357 22.3 1,305 28.3
        ≥ Two-specialty group 106 6.6 398 8.6
    Hospital 446 27.9 1,179 25.5
Teacher (medical students or residents)
    No 756 47.2 2,321 50.2
    Yes 821 51.3 2,236 48.4
    Not ascertained 24 1.5 63 1.4
NCI cancer center affiliation
    No 853 53.3 2,714 58.7
    Yes 434 27.1 1,029 22.3
    Do not know 296 18.5 836 18.1
    Not ascertained 18 1.1 41 0.9
CCOP affiliation
    No 526 32.9 1,396 30.2
    Yes 525 32.8 1,827 39.6
    Do not know 532 33.2 1,352 29.3
    Not ascertained 18 1.1 45 1.0
No. of patients per month
    Colorectal 1,546 4,445
        Mean 7.9 10.4
        SD 12.0 15.6
    Lung 1,543 4,444
        Mean 8.4 11.6
        SD 16.5 20.1
    Patient's cancer type 4,425
        Mean 14.5
        SD 20.4

Patients
Survey type
    Full survey 3,031 65.6
    Surrogate
        Living patient 453 9.8
        Deceased patient 506 11.0
    Brief survey 630 13.6
Age, years
    < 57 1,097 23.7
    57 to 64 893 19.3
    65 to 71 960 20.8
    71 to 78 922 20.0
    > 78 748 16.2
    Not ascertained 2 0.0
Sex
    Male 2,387 51.7
    Female 2,233 48.3
Race
    White 3,279 71.0
    African American 490 10.6
    Other 851 18.4
Marital status
    Unmarried 1,584 34.3
    Married or partnered 2,876 62.3
    Not ascertained 160 3.5
Educational attainment
    < High school 826 17.9
    High school graduate 2,580 55.8
    College graduate 1,165 25.2
    Not ascertained 49 1.1
Annual income
    < $20,000 971 21.0
    $20,000 to $39,999 1,064 23.0
    $40,000 to $59,999 650 14.1
    ≥ $60,000 962 20.8
    Not ascertained 973 21.1
Cancer type
    Colon 1,747 37.8
    Rectal 537 11.6
    Colorectal (unknown site) 204 4.4
    NSCLC 1,908 41.3
    SCLC 224 4.9
Stage at diagnosis
    I 1,049 22.7
    II 904 19.6
    III 1,489 32.2
    IV 1,178 25.5
No. of self-reported comorbid conditions
    0 1,742 37.7
    1 1,302 28.2
    2 592 12.8
    3 328 7.1
    Not ascertained 656 14.2
Treatments received
    Surgery (prior or planned) 3,360 72.7
    Chemotherapy 2,689 58.2
    Radiation therapy 1,311 28.4

Abbreviations: CCOP, community clinical oncology program; HMO, health maintenance organization; NCI, National Cancer Institute; NSCLC, non–small-cell lung cancer; SCLC, small-cell lung cancer; SD, standard deviation; VA, Veterans Affairs.

*

After excluding 67 physicians who did not participate in tumor boards and 140 patient–physician links where physicians did not participate in tumor boards. Among tumor board participants, missing data varied by tumor board feature (69 physicians and 218 links for pretreatment planning function, 70 physicians and 267 links for evaluation of treatment decisions, 76 physicians and 229 links for review of only challenging patient cases, 74 physicians and 261 links for review of variety of cancer sites, and 80 physicians and 279 links for serves only as teaching session).

For 626 patients who completed brief survey, income was not imputed, and we included a dummy variable for missing income. For 25 additional patients, multiple imputation was not performed for some items because of partially completed survey versions; these patients were excluded from multivariable analyses.